Researchers have developed a new model to track inflammation-driven blood clots that can cause complications in sickle cell ...

Purpose. A case of fatal retroperitoneal hematoma that developed after enoxaparin administration in a woman with paroxysmal atrial flutter and chest pain is reported. Summary. A 63-year-old ...

The agents most commonly used for VTE prophylaxis were subcutaneous enoxaparin (70% of cases ... to 72.3% for VTE-4 (monitoring of UFH dosages and platelet counts by protocol).